Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-13-021914

Options or other derivatives

  • SVP & Chief Medical Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Paolo · SVP & Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-04-15 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +150,000 $4.47 2023-04-14 150,000 150,000 D
2013-04-15 Grant or award : show line 2 in the form Restricted Stock Unit +50,000 50,000 50,000 D
Loading xslF345X03/doc4.xml…